Elevance Health (ELV) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $6.99
- Estimate
- $4.69
- Surprise
- +48.9%
- Revenue (period 2026-09-30)
- $51.43B
- Score at report (before → after)
- 5.3 → 5.6/10
Revenue source: xbrl.
How the report landed
Elevance Health (ELV) beat the $4.69 estimate with adjusted EPS of $6.99 — a large 48.9% upside surprise. TrendMatrix's engine moved from Sell (5.3/10) to Hold at 5.6/10 after the report.
Coverage in the report window
- JPMorgan Adjusts Price Target on Elevance Health — fiscal.ai, 2026-10-23
- 10 Health Care Stocks Whale Activity In Today’s Session — benzinga, 2026-10-23
- Deutsche Bank Adjusts Elevance Health Price Target to $493 — fiscal.ai, 2026-10-23
Where TrendMatrix's rating stands now
TrendMatrix currently rates ELV Sell at 5.3/10.
4 of the last 4 quarters beat the estimate; this quarter's +48.9% surprise compares with a +23.2% four-quarter average. Next scheduled report: 2027-01-28.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3)
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $421.68
- Price target
- $434.14
- Stop
- $397.32
- Upside to target
- +3.0%
- Reward-to-risk
- 0.3:1
The stock trades at 17.6× trailing but 13.7× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
ELV at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Healthcare Plans
- Market cap
- $89.87B
- P/E (fwd)
- 13.7
- P/E (ttm)
- 17.6
- 52-week range
- $274.84–$450.69
- Off 52-week high
- 6.4%
- RSI (14)
- 55
- Volume vs avg
- 0.02×
- Score today
- 5.3/10